50-34-0,MFCD00050291
Catalog No.:AA00I8U3

50-34-0 | Propantheline bromide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
≥95%
in stock  
$38.00   $26.00
- +
1g
98%
in stock  
$43.00   $30.00
- +
5g
98%
in stock  
$99.00   $69.00
- +
25g
98%
in stock  
$353.00 $247.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00I8U3
Chemical Name:
Propantheline bromide
CAS Number:
50-34-0
Molecular Formula:
C23H30BrNO3
Molecular Weight:
448.3932
MDL Number:
MFCD00050291
SMILES:
O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C.[Br-]
NSC Number:
757294
Properties
Properties
 
Form:
Solid  
MP:
159-161°C  
Refractive Index:
1.6200 (estimate)  
Solubility:
H2O: soluble50mg/mL  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
474  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: The influence of spasmolytic agents on heart rate variability and gastrointestinal motility in normal horses.

Journal: Research in veterinary science 20121201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Journal: Nature chemical biology 20091001

Title: Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection.

Journal: Drug metabolism and pharmacokinetics 20090101

Title: Response to 'Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection'.

Journal: Drug metabolism and pharmacokinetics 20090101

Title: Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101

Title: Pharmacological interventions for clozapine-induced hypersalivation.

Journal: Schizophrenia bulletin 20080701

Title: Using the zebrafish lateral line to screen for ototoxicity.

Journal: Journal of the Association for Research in Otolaryngology : JARO 20080601

Title: Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity?

Journal: Mutagenesis 20080301

Title: Clomipramine-induced mood and perceived performance changes in selected healthy individuals.

Journal: Journal of clinical psychopharmacology 20070601

Title: The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.

Journal: TheScientificWorldJournal 20070101

Title: Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy.

Journal: The Tohoku journal of experimental medicine 20061201

Title: Masking mechanisms of bitter taste of drugs studied with ion selective electrodes.

Journal: Chemical & pharmaceutical bulletin 20060801

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Propantheline and in vitro reactivity of urinary bladder smooth muscle in guinea pigs.

Journal: Bratislavske lekarske listy 20050101

Title: Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Journal: Journal of medicinal chemistry 20031009

Title: Taurine in submandibular gland of the rat: effect of muscarinic drugs.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20020401

Title: An improved method of evaluation of drug-evoked changes in gastric emptying in mice.

Journal: Journal of pharmacological and toxicological methods 20020101

Title: [Protein-losing syndrome of the gastrointestinal tract].

Journal: Deutsche medizinische Wochenschrift (1946) 20011026

Title: A stability-indicating proton nuclear magnetic resonance spectroscopic method for the analysis of propantheline bromide in pharmaceutical samples.

Journal: Die Pharmazie 20010901

Title: Stoichiometric and microenvironmental effects on hydrolysis of propantheline and oxyphenonium bromides in cyclodextrin solutions.

Journal: Journal of pharmaceutical sciences 20010601

Title: Swallow syncope.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 19860801

Title: Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.

Journal: The American journal of medicine 19841119

Title: Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide.

Journal: Journal of pharmaceutical sciences 19771001

Title: Blood levels and management of lithium treatment.

Journal: British medical journal 19740914

Title: J Mokry, et al. Propantheline and in vitro reactivity of urinary bladder smooth muscle in guinea pigs. Bratisl Lek Listy. 2005;106(4-5):151-4.

Title: Richard Jewell, et al. Propantheline. xPharm: The Comprehensive Pharmacology Reference. 2007, Pages 1-5.

Title: S Kobayashi, et al. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo. Jpn J Pharmacol. 2001 Jul;86(3):281-8.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 50-34-0
Tags:50-34-0 Molecular Formula|50-34-0 MDL|50-34-0 SMILES|50-34-0 Propantheline bromide
Catalog No.: AA00I8U3
50-34-0,MFCD00050291
50-34-0 | Propantheline bromide
Pack Size: 500mg
Purity: ≥95%
in stock
$38.00 $26.00
Pack Size: 1g
Purity: 98%
in stock
$43.00 $30.00
Pack Size: 5g
Purity: 98%
in stock
$99.00 $69.00
Pack Size: 25g
Purity: 98%
in stock
$353.00 $247.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00I8U3
Chemical Name: Propantheline bromide
CAS Number: 50-34-0
Molecular Formula: C23H30BrNO3
Molecular Weight: 448.3932
MDL Number: MFCD00050291
SMILES: O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C.[Br-]
NSC Number: 757294
Properties
Form: Solid  
MP: 159-161°C  
Refractive Index: 1.6200 (estimate)  
Solubility: H2O: soluble50mg/mL  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 474  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: The influence of spasmolytic agents on heart rate variability and gastrointestinal motility in normal horses.

Journal: Research in veterinary science20121201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Journal: Nature chemical biology20091001

Title: Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection.

Journal: Drug metabolism and pharmacokinetics20090101

Title: Response to 'Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection'.

Journal: Drug metabolism and pharmacokinetics20090101

Title: Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V20081101

Title: Pharmacological interventions for clozapine-induced hypersalivation.

Journal: Schizophrenia bulletin20080701

Title: Using the zebrafish lateral line to screen for ototoxicity.

Journal: Journal of the Association for Research in Otolaryngology : JARO20080601

Title: Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity?

Journal: Mutagenesis20080301

Title: Clomipramine-induced mood and perceived performance changes in selected healthy individuals.

Journal: Journal of clinical psychopharmacology20070601

Title: The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.

Journal: TheScientificWorldJournal20070101

Title: Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy.

Journal: The Tohoku journal of experimental medicine20061201

Title: Masking mechanisms of bitter taste of drugs studied with ion selective electrodes.

Journal: Chemical & pharmaceutical bulletin20060801

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Propantheline and in vitro reactivity of urinary bladder smooth muscle in guinea pigs.

Journal: Bratislavske lekarske listy20050101

Title: Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Journal: Journal of medicinal chemistry20031009

Title: Taurine in submandibular gland of the rat: effect of muscarinic drugs.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society20020401

Title: An improved method of evaluation of drug-evoked changes in gastric emptying in mice.

Journal: Journal of pharmacological and toxicological methods20020101

Title: [Protein-losing syndrome of the gastrointestinal tract].

Journal: Deutsche medizinische Wochenschrift (1946)20011026

Title: A stability-indicating proton nuclear magnetic resonance spectroscopic method for the analysis of propantheline bromide in pharmaceutical samples.

Journal: Die Pharmazie20010901

Title: Stoichiometric and microenvironmental effects on hydrolysis of propantheline and oxyphenonium bromides in cyclodextrin solutions.

Journal: Journal of pharmaceutical sciences20010601

Title: Swallow syncope.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques19860801

Title: Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.

Journal: The American journal of medicine19841119

Title: Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide.

Journal: Journal of pharmaceutical sciences19771001

Title: Blood levels and management of lithium treatment.

Journal: British medical journal19740914

Title: J Mokry, et al. Propantheline and in vitro reactivity of urinary bladder smooth muscle in guinea pigs. Bratisl Lek Listy. 2005;106(4-5):151-4.

Title: Richard Jewell, et al. Propantheline. xPharm: The Comprehensive Pharmacology Reference. 2007, Pages 1-5.

Title: S Kobayashi, et al. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo. Jpn J Pharmacol. 2001 Jul;86(3):281-8.

Building Blocks More >
50586-80-6
50586-80-6
M-Peg3-tos
AA00I90A | MFCD13184964
517-28-2
517-28-2
Hematoxylin hydrate
AA00I95Z | MFCD00078111
52436-42-7
52436-42-7
Propargyl-peg2-acrylate
AA00I9AZ | MFCD24539475
5326-82-9
5326-82-9
2-Chloro-N,N-diisobutylacetamide
AA00I9FJ | MFCD00040035
5401-94-5
5401-94-5
5-Nitro-1H-indazole
AA00I9KE | MFCD00005693
54616-46-5
54616-46-5
2-Iodo-N,N-dimethylbenzamide
AA00I9ON | MFCD00463660
55559-31-4
55559-31-4
Benzo[d]isoxazol-7-ol
AA00I9U8 | MFCD09027559
56285-96-2
56285-96-2
D-Glucose, 4-O-(2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl)-,2,3,6-triacetate
AA00I9Z8 | MFCD28397800
571919-39-6
571919-39-6
2-((5-[(4-Ethylphenyl)amino]-1,3,4-thiadiazol-2-yl)sulfanyl)acetic acid
AA00IA4C | MFCD04612074
58-86-6
58-86-6
D-Xylose
AA00IA8Q | MFCD00151475
Submit
© 2017 AA BLOCKS, INC. All rights reserved.